Quantcast

Friday, September 25, 2009

Wednesday, September 16, 2009

Oral Insulin

1) The FDA has approved Oral-lyn, an insulin spray treatment for type I and type II diabetes, for its Investigational New Drug program.


The spray delivers prandial insulin orally through a device similar to an asthma inhaler, which sprays it on the inside of the cheek, rather than via injection.

Researchers have spent much time looking for alternative means of dispensing insulin to diabetics, and the IND program allows patients with serious or life-threatening conditions, and without suitable alternative treatment, to access drugs otherwise available only to those in a clinical trial.



2) Oramed has developed a tablet form of insulin in which the hormone's protein structure is supposedly protected by special adjuvants from destruction by gastric juice. The firm just reported positive results from a Phase 2A clinical trial with Type I diabetics.

Saturday, September 5, 2009

Depression in Teens


http://www.mentalhealthamerica.net/go/information/get-info/depression/depression-in-teens
Source: mentalhealthamerica.net
 

New antioxidants extracted from cellwalls of fruits

Check out this link for detailed information on Drugs.com: http://www.drugs.com/news/fruit-even-healthier-than-thought-study-19704.html
The website is http://www.drugs.com/, which has a database of over 24,000 drugs, plus a Drug Interactions checker and a pictorial Pill Identifier.

Thursday, September 3, 2009

Medscape: Antisense Molecule Shows Promise in Duchenne

Medscape from WebMD - Email This

A link to the following article was sent to you by: Mohd Tariq Salman

Antisense Molecule Shows Promise in Duchenne Muscular Dystrophy
Medscape Medical News , 2009-08-26

This message was sent to: mtariqsalman.medicalresearch@blogger.com

Medscape
attn: Member Support
111 Eighth Avenue
New York, NY 10011

Free Books, powerpoint presentations, teaching tools and resources and drug information